| 摘要 |
The invention is directed to novel, purified and isolated IL-1 zeta, IL-1 ze ta splice variants, and Xrec2 polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.
|
